Hologic Stock Analysis
| HOLX Stock | USD 74.81 0.11 0.15% |
IPO Date 21st of June 1990 | 200 Day MA 68.0659 | 50 Day MA 74.879 | Beta 0.733 |
Hologic holds a debt-to-equity ratio of 0.569. At this time, Hologic's Net Debt is fairly stable compared to the past year. Net Debt To EBITDA is likely to rise to 0.40 in 2026, whereas Short and Long Term Debt Total is likely to drop slightly above 1.9 B in 2026. With a high degree of financial leverage come high-interest payments, which usually reduce Hologic's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Hologic's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Hologic's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Hologic Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Hologic's stakeholders.
For many companies, including Hologic, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Hologic, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Hologic's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 3.1794 | Enterprise Value Ebitda 15.6869 | Price Sales 4.0472 | Shares Float 221.2 M | Wall Street Target Price 76.6 |
Hologic is fairly valued with Real Value of 75.67 and Target Price of 76.6. The main objective of Hologic stock analysis is to determine its intrinsic value, which is an estimate of what Hologic is worth, separate from its market price. There are two main types of Hologic's stock analysis: fundamental analysis and technical analysis.
The Hologic stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Hologic is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Hologic Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Hologic Stock Analysis Notes
About 97.0% of the company shares are owned by institutional investors. The book value of Hologic was currently reported as 23.51. The company has Price/Earnings To Growth (PEG) ratio of 1.51. Hologic had not issued any dividends in recent years. The entity had 2:1 split on the 3rd of April 2008. Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. Hologic operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 6705 people. To learn more about Hologic call Stephen MacMillan at 508 263 2900 or check out https://www.hologic.com.Hologic Quarterly Total Revenue |
|
Hologic Investment Alerts
| Hologic has a strong financial position based on the latest SEC filings | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Oligonucleotide Synthesis Market Forecasts 2026-2031 by Oligo Length, Application, Category, Type, Product, and Region, with Executive and Consultant Guides |
Hologic Largest EPS Surprises
Earnings surprises can significantly impact Hologic's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2006-01-24 | 2005-12-31 | 0.07 | 0.06 | -0.01 | 14 | ||
2005-11-02 | 2005-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2005-04-27 | 2005-03-31 | 0.06 | 0.07 | 0.01 | 16 |
Hologic Environmental, Social, and Governance (ESG) Scores
Hologic's ESG score is a quantitative measure that evaluates Hologic's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Hologic's operations that may have significant financial implications and affect Hologic's stock price as well as guide investors towards more socially responsible investments.
Hologic Thematic Classifications
In addition to having Hologic stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | SRI Sustainable GrowthLarge and mid-sized companies that operate under the guidelines of socially responsible investing - SRI | |
![]() | Obamacare RepealLarge healthcare related equities associated with Obamacare |
Hologic Stock Institutional Investors
| Shares | Northern Trust Corp | 2025-06-30 | 2.8 M | Arrowstreet Capital Limited Partnership | 2025-06-30 | 2.8 M | Norges Bank | 2025-06-30 | 2.8 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 2.6 M | Nordea Investment Mgmt Bank Demark A/s | 2025-06-30 | 2.6 M | Dimensional Fund Advisors, Inc. | 2025-06-30 | 2.5 M | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 2.4 M | Alliancebernstein L.p. | 2025-06-30 | 2.2 M | Ameriprise Financial Inc | 2025-06-30 | 1.9 M | Vanguard Group Inc | 2025-06-30 | 26.8 M | T. Rowe Price Investment Management,inc. | 2025-06-30 | 24.1 M |
Hologic Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 16.7 B.Hologic Profitablity
The company has Profit Margin (PM) of 0.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.16 | 0.17 | |
| Return On Capital Employed | 0.11 | 0.08 | |
| Return On Assets | 0.09 | 0.09 | |
| Return On Equity | 0.15 | 0.16 |
Management Efficiency
Hologic has return on total asset (ROA) of 0.0743 % which means that it generated a profit of $0.0743 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1086 %, meaning that it created $0.1086 on every $100 dollars invested by stockholders. Hologic's management efficiency ratios could be used to measure how well Hologic manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Hologic's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.09 in 2026, whereas Return On Capital Employed is likely to drop 0.08 in 2026. At this time, Hologic's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 4.4 B in 2026, whereas Non Current Assets Total are likely to drop slightly above 3.2 B in 2026.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 21.76 | 22.85 | |
| Tangible Book Value Per Share | 3.57 | 3.75 | |
| Enterprise Value Over EBITDA | 15.20 | 15.96 | |
| Price Book Value Ratio | 3.74 | 3.56 | |
| Enterprise Value Multiple | 15.20 | 15.96 | |
| Price Fair Value | 3.74 | 3.56 | |
| Enterprise Value | 16.8 B | 17.7 B |
The decision-making processes within Hologic are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Technical Drivers
As of the 8th of February, Hologic retains the Risk Adjusted Performance of 0.034, market risk adjusted performance of 0.0941, and Downside Deviation of 0.1617. Hologic technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Hologic Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Hologic price series with the more recent values given greater weights.
Hologic Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hologic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hologic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Hologic insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Hologic Outstanding Bonds
Hologic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hologic uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hologic bonds can be classified according to their maturity, which is the date when Hologic has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Hologic 4625 percent Corp BondUS436440AM32 | View | |
| HOLOGIC INC 325 Corp BondUS436440AP62 | View |
Hologic Predictive Daily Indicators
Hologic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Hologic stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Hologic Corporate Filings
8K | 6th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 3rd of February 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 29th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 26th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10K | 22nd of January 2026 An amendment to a previously filed Form 10-K | ViewVerify |
| 12th of January 2026 Other Reports | ViewVerify | |
| 23rd of December 2025 Other Reports | ViewVerify | |
F4 | 16th of December 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Hologic Forecast Models
Hologic's time-series forecasting models are one of many Hologic's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hologic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Hologic Bond Ratings
Hologic financial ratings play a critical role in determining how much Hologic have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Hologic's borrowing costs.| Piotroski F Score | 7 | Strong | View |
| Beneish M Score | (2.83) | Unlikely Manipulator | View |
Hologic Debt to Cash Allocation
As Hologic follows its natural business cycle, the capital allocation decisions will not magically go away. Hologic's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Hologic currently holds 2.63 B in liabilities with Debt to Equity (D/E) ratio of 0.57, which is about average as compared to similar companies. Hologic has a current ratio of 3.82, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Hologic's use of debt, we should always consider it together with its cash and equity.Hologic Total Assets Over Time
Hologic Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Hologic uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Hologic Debt Ratio | 19.0 |
Hologic Corporate Bonds Issued
Hologic Short Long Term Debt Total
Short Long Term Debt Total |
|
About Hologic Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Hologic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hologic shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hologic. By using and applying Hologic Stock analysis, traders can create a robust methodology for identifying Hologic entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.21 | 0.23 | |
| Operating Profit Margin | 0.22 | 0.23 | |
| Net Profit Margin | 0.20 | 0.21 | |
| Gross Profit Margin | 0.55 | 0.40 |
Current Hologic Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Hologic analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Hologic analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 76.6 | Buy | 20 | Odds |
Most Hologic analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Hologic stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Hologic, talking to its executives and customers, or listening to Hologic conference calls.
Hologic Stock Analysis Indicators
Hologic stock analysis indicators help investors evaluate how Hologic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Hologic shares will generate the highest return on investment. By understating and applying Hologic stock analysis, traders can identify Hologic position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 2.2 B | |
| Long Term Debt | 2.5 B | |
| Common Stock Shares Outstanding | 227.6 M | |
| Total Stockholder Equity | 5 B | |
| Total Cashflows From Investing Activities | -482.7 M | |
| Tax Provision | 115.5 M | |
| Quarterly Earnings Growth Y O Y | -0.092 | |
| Property Plant And Equipment Net | 653.7 M | |
| Cash And Short Term Investments | 2.2 B | |
| Cash | 2 B | |
| Accounts Payable | 193.4 M | |
| Net Debt | 667.3 M | |
| 50 Day M A | 74.879 | |
| Total Current Liabilities | 977.2 M | |
| Other Operating Expenses | 3.4 B | |
| Non Current Assets Total | 5.3 B | |
| Forward Price Earnings | 16.3399 | |
| Non Currrent Assets Other | 145.1 M | |
| Stock Based Compensation | 84.3 M |
Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.

